Vaccinology in the third millennium

Scientific and social challenges

Gregory A. Poland, Jennifer A. Whitaker, Caroline M. Poland, Inna G. Ovsyannikova, Richard B Kennedy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The epidemiology of deaths due to vaccine-preventable diseases has been significantly and positively altered through the use of vaccines. Despite this, significant challenges remain in vaccine development and use in the third millennium. Both new (Ebola, Chikungunya, Zika, and West Nile) and re-emerging diseases (measles, mumps, and influenza) require the development of new or next-generation vaccines. The global aging of the population, and accumulating numbers of immunocompromised persons, will require new vaccine and adjuvant development to protect large segments of the population. After vaccine development, significant challenges remain globally in the cost and efficient use and acceptance of vaccines by the public. This article raises issues in these two areas and suggests a way forward that will benefit current and future generations.

Original languageEnglish (US)
Pages (from-to)116-125
Number of pages10
JournalCurrent Opinion in Virology
Volume17
DOIs
StatePublished - Apr 1 2016

Fingerprint

Vaccines
Mumps
Social Responsibility
Measles
Human Influenza
Population
Epidemiology
Costs and Cost Analysis

ASJC Scopus subject areas

  • Virology

Cite this

Vaccinology in the third millennium : Scientific and social challenges. / Poland, Gregory A.; Whitaker, Jennifer A.; Poland, Caroline M.; Ovsyannikova, Inna G.; Kennedy, Richard B.

In: Current Opinion in Virology, Vol. 17, 01.04.2016, p. 116-125.

Research output: Contribution to journalArticle

Poland, Gregory A. ; Whitaker, Jennifer A. ; Poland, Caroline M. ; Ovsyannikova, Inna G. ; Kennedy, Richard B. / Vaccinology in the third millennium : Scientific and social challenges. In: Current Opinion in Virology. 2016 ; Vol. 17. pp. 116-125.
@article{6a810d9abc934885b3289d6362fdee0a,
title = "Vaccinology in the third millennium: Scientific and social challenges",
abstract = "The epidemiology of deaths due to vaccine-preventable diseases has been significantly and positively altered through the use of vaccines. Despite this, significant challenges remain in vaccine development and use in the third millennium. Both new (Ebola, Chikungunya, Zika, and West Nile) and re-emerging diseases (measles, mumps, and influenza) require the development of new or next-generation vaccines. The global aging of the population, and accumulating numbers of immunocompromised persons, will require new vaccine and adjuvant development to protect large segments of the population. After vaccine development, significant challenges remain globally in the cost and efficient use and acceptance of vaccines by the public. This article raises issues in these two areas and suggests a way forward that will benefit current and future generations.",
author = "Poland, {Gregory A.} and Whitaker, {Jennifer A.} and Poland, {Caroline M.} and Ovsyannikova, {Inna G.} and Kennedy, {Richard B}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.coviro.2016.03.003",
language = "English (US)",
volume = "17",
pages = "116--125",
journal = "Current Opinion in Virology",
issn = "1879-6257",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Vaccinology in the third millennium

T2 - Scientific and social challenges

AU - Poland, Gregory A.

AU - Whitaker, Jennifer A.

AU - Poland, Caroline M.

AU - Ovsyannikova, Inna G.

AU - Kennedy, Richard B

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The epidemiology of deaths due to vaccine-preventable diseases has been significantly and positively altered through the use of vaccines. Despite this, significant challenges remain in vaccine development and use in the third millennium. Both new (Ebola, Chikungunya, Zika, and West Nile) and re-emerging diseases (measles, mumps, and influenza) require the development of new or next-generation vaccines. The global aging of the population, and accumulating numbers of immunocompromised persons, will require new vaccine and adjuvant development to protect large segments of the population. After vaccine development, significant challenges remain globally in the cost and efficient use and acceptance of vaccines by the public. This article raises issues in these two areas and suggests a way forward that will benefit current and future generations.

AB - The epidemiology of deaths due to vaccine-preventable diseases has been significantly and positively altered through the use of vaccines. Despite this, significant challenges remain in vaccine development and use in the third millennium. Both new (Ebola, Chikungunya, Zika, and West Nile) and re-emerging diseases (measles, mumps, and influenza) require the development of new or next-generation vaccines. The global aging of the population, and accumulating numbers of immunocompromised persons, will require new vaccine and adjuvant development to protect large segments of the population. After vaccine development, significant challenges remain globally in the cost and efficient use and acceptance of vaccines by the public. This article raises issues in these two areas and suggests a way forward that will benefit current and future generations.

UR - http://www.scopus.com/inward/record.url?scp=84962197773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962197773&partnerID=8YFLogxK

U2 - 10.1016/j.coviro.2016.03.003

DO - 10.1016/j.coviro.2016.03.003

M3 - Article

VL - 17

SP - 116

EP - 125

JO - Current Opinion in Virology

JF - Current Opinion in Virology

SN - 1879-6257

ER -